
@JCO_ASCO: TURBO-NSCLC (ascopubs.org/doi/10.1200/JCO…) was a multi-institutional cohort study of 317 treatment-naive EGFR or ALK NSCLC pts with Brain Mets who received TKI w/wo up-front SRS. SRS was associated with superior CNS control. @MSK_RadOnc @MSKCancerCenter










